Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

San Diego Office
3985A Sorrento Valley Boulevard
San Diego, CA, 92121
USA
Menlo Park Office
1010 El Camino Real, STe 380
Menlo Park, CA, 94025
USA

People

CMO
CFO
CSO
CTO
VP Project Management
VP Operations
Board of Directors
Board of Directors
Show All People

Funding

TOTAL $24M
FUNDING TOTAL $24M
Venture Round, 11/2009
Ignition Partners
$2M
Series B, 12/2013
Ignition Growth
Blue Haven Initiative
Ignition Partners
$22M
DEBT TOTAL $37.6M
Debt, 10/2010
$35.1M
Debt, 10/2013
$2.5M

Tags

PaxVax

PaxVax is a vaccine start-up company developing candidate oral vaccines for influenza, and key infectious diseases.

PaxVax has developed a proprietary oral vaccine technology based on a common virus called adenovirus. The technology removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and administration by medical personnel.

PaxVax has raised more than $50 million from investors including Ignition Partners and the Wellcome Trust, and is supported by grants from the U.S. National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID) and its Division of Acquired Immunodeficiency Syndrome (DAIDS), as well as the Bill and Melinda Gates Foundation.

Recent Milestones

Videos

Screenshots

Sources

  1. Xconomy San Diego (xconomy.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. PaxVax Completes $22M Series B Financing (finsmes.com) [edit]
  5. FDA Accepts PaxVax’s IND for Single-Dose Oral Cholera Vaccine (paxvax.com) [edit]
Edit This Page
Last Edited 3/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy